{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"18.857","upperLimit":"20.714","value":"19.8"},{"comment":"Median overall survival was not reached in some arms at the time of data cutoff due to ongoing survival; therefore, median OS and associated confidence intervals are not reported for those arms.","groupId":"OG001","lowerLimit":"NA","upperLimit":"NA","value":"NA"},{"comment":"Upper confidence interval bounds were not estimable in some arms due to censoring","groupId":"OG002","lowerLimit":"25.429","upperLimit":"NA","value":"42.9"},{"comment":"Median overall survival was not reached in some arms at the time of data cutoff due to ongoing survival; therefore, median OS and associated confidence intervals are not reported for those arms.","groupId":"OG003","lowerLimit":"11.571","upperLimit":"NA","value":"NA"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"4"}],"units":"Participants"}],"description":"OS was defined as the time from the date of afamitresgene autoleucel infusion to the date of death (due to any reason).","dispersionType":"95% Confidence Interval","groups":[{"description":"Participants who received afamitresgene autoleucel 0.1x10\\^9 transduced cells","id":"OG000","title":"Afamitresgene Autoleucel, Group 1"},{"description":"Participants who received afamitresgene autoleucel 0.5-1.2x10\\^9 transduced cells","id":"OG001","title":"Afamitresgene Autoleucel, Group 2"},{"description":"Participants who received afamitresgene autoleucel 1.2-10x10\\^9 transduced cells","id":"OG002","title":"Afamitresgene Autoleucel Group 3 + Expansion"},{"description":"Participants who received LDR in combination with lymphodepletion chemotherapy followed by the afamitresgene autoleucel infusion (1.2-10x10\\^9 transduced cells).","id":"OG003","title":"Substudy: Low Dose Radiation (LDR) in Combination With Afamitresgene Autoleucel"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"From afamitresgene autoleucel infusion until death due to any reason or censored date From afamitresgene autoleucel infusion until death due to any reason or censored date","title":"Overall Survival (OS)","type":"SECONDARY","unitOfMeasure":"Weeks"}